Clinical Trial: A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975722) titled 'A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis' on April 28.

Brief Summary: This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Ulcerative Colitis. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Ulcerative Colitis. The total study duration is up to 169 weeks and the treatment duration is up to 158 weeks

Study Start Date: June 03

Study Type: INTERVENTIONAL

Condition: Ulcerative Colitis

Intervention: DRUG: SAR442970

Route of administrati...